Viewing nowNeurotan Tablet (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Korea Union Pharm Co., Ltd.

MFDS item code 200501420 · Notified 2005.03.31 · Insurance code 665500270
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
This medication is used to treat hypertension. Additionally, it helps to prevent or delay the progression of nephropathy in patients with hypertension and type 2 diabetes. Therefore, it is effective in managing hypertension and preventing diabetic kidney complications.
This medicine may be taken without regard to meals, but it is recommended to take it at the same time every day. Adults with hypertension: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is inadequate, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed when administered in combination with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with insulin and commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years and older who weigh 20 kg or more but less than 50 kg and are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years and older who weigh 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Not recommended for children under 6 years of age, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.
This medication can cause serious harm or even death to the fetus if taken during pregnancy, especially in the second and third trimesters, thus, it should not be taken by pregnant women or women who may become pregnant. Patients with allergies to this medication, severe liver dysfunction, certain genetic disorders, or severe kidney disease should also avoid it. Elderly patients or patients who are prone to high potassium levels, or those with liver or heart issues should use this medication cautiously, as there is a risk of excessively low blood pressure or worsening kidney function. Side effects such as muscle cramps, dizziness, cough, and indigestion may occur during treatment, and in rare cases, serious allergic reactions, hepatitis, or renal failure may develop, prompt consultation with a physician is advised if unusual symptoms arise. When taken with other antihypertensive medications, diuretics, or potassium supplements, there may be an increased risk of side effects due to interactions, hence patients must inform their doctor about all medications they are taking. Regular blood pressure and blood tests to monitor kidney function and electrolyte levels during treatment are crucial. Pregnant patients should discontinue this medication and seek other safe treatment options, and it is also advisable to avoid use while breastfeeding. This medication is not recommended for children, especially those under 6 years old, or for those with significantly reduced renal function. In case of overdose, symptoms like hypotension and arrhythmias may occur, requiring immediate medical attention as this medication is not removed by dialysis, hence professional treatment is needed. Store this medication out of reach of children and do not transfer it to other containers for safety. Caution should be exercised during activities requiring alertness, such as driving or operating machinery, as sudden dizziness or fainting may occur.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture. Additionally, it should be kept in a cool place, maintaining a temperature between 1 to 30 degrees Celsius. Avoid direct sunlight or high temperatures for safe storage.
White oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLosartan Potassium 50mg
Tablet · Prescription medication
Korea Union Pharm Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.